NEWS

ELPEN wins the Athens Chamber of Commerce and Industry (ACCI) R&D Award

26 June 2014

On June 23, 2014 ELPEN was awarded for the second time since 2005 with the "Research & Technological Development" award, by the Athens Chamber of Commerce and Industry (ACCI). This specific award comprises the third distinction within a month for ELPEN. It follows the award given to the company on May 22nd with the award regarding "Employment Growth", which award is given in the context ofthe Business Excellence Awards for "The Most Admired Enterprises". On June 13th, the Chairman, CEO of ELPEN, Mr. Dimitrios Pentafragas, was presented with the award by the Greek Society of Pharmacology and Clinical Pharmacology, at the Research Center of the Athens Academy.

Dimitrios Pentafragas, Founder and Chairman of ELPEN Pharmaceutical Co. Inc. is awarded for his substantial contribution to pharmaceutical research in Greece

13 June 2014

An important and moving awards ceremony took place at the Athens Academy Research Center, where the Founder and Chairman of ELPEN Pharmaceutical Co. Inc. was awarded by the Greek Association of Pharmacology and Clinical Pharmacology. The award honored Mr. D. Pentafragas's substantial contribution and long-standing commitment to clinical research aswell as his pioneering support and encouragement to researchers, nationally and internationally, by establishing the ELPEN Experimental and Research Center which focuses on scientific research and innovation in the pharmaceutical field.

20 May 2014

14 May 2014

"Stop experimenting with drug prices", as was stated by Mr. Theodore Tryfon

14 November 2013

A profound appeal to stop experimenting with drug prices was made by the Vice President of the Panhellenic Association of Pharmaceutical Industries (PEF) Mr. Theodore Tryfon, to the leadership of the Greek Ministry of Health on Wednesday, November 13, at a Stat Bank event entitled "Health-Drugs-Beauty 2013".

"Greek pharmaceutical companies adhere strictly to international standards", states Professor Machairas

11 November 2013

The fact that the Greek Pharmaceutical Industry meets high production standards was highlighted by Professor Panagiotis Machairas, Biopharmaceutics & Pharmacokinetics, National & Kapodistrian University of Athens, in his speech at the 1st Greek National Conference on "Crisis Management in Healthcare".

Pharmaceutical expenditure cutbacks pose a great health risk to patients, as stated by leading representatives of the Greek Pharmaceutical sector

09 November 2013

An appeal to increase pharmaceutical expenditure in order to ensure the patients's access to reliable and qualitative treatments was made by the leaders of the Pharma sector on Saturday, November 9, at the 1st Greek National Conference on "Crisis Management in the Pharmaceutical Sector".

ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler^{^®}

31 October 2013

ELPEN drugs are exported to 60 countries worldwide, 27 of which are in Europe, with the primary aim to achieve further global expansion, spearheaded by Elpenhaler®, an original product, patented by the company's founder, Mr. Dimitrios Pentafragas.